2012-04-12 12:15:00 CEST

2012-04-12 12:15:40 CEST


REGULATED INFORMATION

English
Okmetic Oyj - Decisions of general meeting

DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ


OKMETIC OYJ            STOCK EXCHANGE RELEASE     12 APRIL 2012   AT 1.15 P.M.


DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ

The annual general meeting of Okmetic Oyj was held on 12 April 2012, at 10.00
a.m. in the Finnish Aviation Museum, address Tietotie 3, Vantaa, Finland. The
annual general meeting adopted the annual accounts and the consolidated annual
accounts for the financial year 2011 and discharged the company's management
from liability.

USE OF THE PROFITS SHOWN ON THE BALANCE SHEET AND PAYMENT OF DIVIDEND

The annual general meeting decided, in accordance with the proposal of the board
of directors, to distribute a dividend of 0.28 euro per share. Dividend will be
paid to a shareholder, who, on the record date 17 April 2012, is registered in
the shareholders' register held by Euroclear Finland Ltd. Dividend will be paid
on 24 April 2012.

In addition, the annual general meeting decided, in accordance with the proposal
of the board of directors, to authorise the board of directors to decide upon
its discretion on the payment of an additional dividend, should the company's
financial situation permit this. The additional dividend, including all possible
separate decisions on dividend payment, may amount up to a maximum of 0.40 euro
per share and 15,000,000 euro in total. Any dividend paid on the basis of the
board's decision will be paid to a shareholder who, on the record date
determined by the board of directors, is registered in the shareholders'
register held by Euroclear Finland Ltd. The board of directors will decide the
record date of the dividend payout and the dividend payment date which may, at
the earliest, be the fifth banking day after the record date.  The authorisation
includes the right for the board of directors to decide on all other terms and
conditions relating to the payment of additional dividend. The authorisation is
effective until the beginning of the next annual general meeting.

ELECTION AND REMUNERATION OF THE MEMBERS OF THE BOARD OF DIRECTORS

It was decided that there would be five members on the company's board of
directors. Mr. Henri Österlund, Mr. Tapani Järvinen, Mr. Hannu Martola, and Ms.
Mervi Paulasto-Kröckel were re-elected as members of the board of directors, and
Mr. Mikko Puolakka was elected as a new member of the board of directors, all
until the end of the next annual general meeting. The board of directors elected
Henri Österlund as its chairman and Tapani Järvinen as its vice chairman in its
organisation meeting held immediately after the annual general meeting.

It was decided that the following annual remuneration shall be paid to the
members of the board of directors: 40,000 euro to the chairman, 30,000 euro to
the vice chairman, and 20,000 euro to the other members of the board of
directors. The annual remuneration will be paid in the company's shares and in
cash for the part of taxes. Payment of the annual remuneration will be made as a
one-time payment on 10 May 2012. The number of remuneration shares shall be
determined according to the closing quotation of the company's share on 9 May
2012. In addition, it was decided that the board members will be paid meeting
remuneration, amount of which is 750 euro/meeting for the chairman and 500
euro/meeting for other board members.

ELECTION AND REMUNERATION OF THE AUDITOR

Authorised Public Accountants PricewaterhouseCoopers Oy was re-elected as
auditor of the company. PricewaterhouseCoopers Oy has announced that APA Mikko
Nieminen will be acting as principal auditor. It was decided that remuneration
to the auditor shall be paid according to the auditor's reasonable invoice.

AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON THE REPURCHASE AND/OR
ACCEPTANCE AS PLEDGE OF THE COMPANY'S OWN SHARES

The general meeting authorised the board of directors to decide on the
repurchase and/or acceptance as pledge of the company's own shares in one or
more tranches as follows:

The aggregate number of own shares to be repurchased and/or accepted as pledge
shall not exceed 1,728,750 shares, which represents approximately 10 percent of
all the shares of the company. The company and its subsidiaries together cannot
at any time own and/or hold as pledge more than 10 percent of all the company's
registered shares.

Only unrestricted equity can be used to repurchase the company's own shares on
the basis of the authorisation. Own shares can be repurchased at a price
determined by public trading on the day of the repurchase or at another market-
based price.

The board of directors decides on the method of repurchasing and/or accepting as
pledge of the company's own shares as well as the other terms and conditions.
Shares can be repurchased otherwise than in the shareholders' proportional
holding of shares (directed repurchase). The authorisation cancels the
authorisation given by the annual general meeting on 7 April 2011 to the board
of directors to decide on the repurchase and/or acceptance as a pledge of the
company's own shares. The authorisation is effective until the next annual
general meeting, however, no longer than until 12 October 2013.

AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON THE ISSUANCE OF SHARES, THE
TRANSFER OF THE COMPANY'S OWN SHARES AS WELL AS THE ISSUANCE OF SPECIAL RIGHTS
ENTITLING TO SHARES

The general meeting authorised the board of directors to decide on the issuance
of shares, the transfer of the company's own shares, and the issuance of special
rights entitling to shares according to Chapter 10, Section 1 of the Finnish
Companies Act in one or more tranches as follows:

The aggregate number of shares issued or transferred on the basis of the
authorisation may not exceed 5,200,000 shares.

The board of directors decides on all the terms and conditions of the issuance
of shares, the transfer of the company's own shares, and the issuance of special
rights entitling to shares according to Chapter 10, Section 1 of the Finnish
Companies Act. The authorisation concerns both the issuance of new shares as
well as the transfer of the company's own shares. The issuance of shares, the
transfer of the company's own shares, and the issuance of special rights
entitling to shares according to Chapter 10, Section 1 of the Finnish Companies
Act may be carried out in deviation from the shareholders' pre-emptive rights
(directed issue).

The authorisation cancels the authorisations given by the annual general meeting
on 7 April 2011 to the board of directors to decide on the transfer of rights to
the company's own shares as well as to decide on the issuance of shares and the
issuance of special rights entitling to shares. The authorisation is effective
until the next annual general meeting, however, no longer than until 12 October
2013.

PRESIDENT'S REVIEW AT THE ANNUAL GENERAL MEETING

The review of President Kai Seikku is available on the company's website at
www.okmetic.com/www/page/general_meeting.


OKMETIC OYJ

Kai Seikku
President

For further information, please contact:

Kai Seikku, President, Okmetic Oyj,
Tel. +358 400 200 288, e-mail: kai.seikku@okmetic.com

Juha Jaatinen, Senior Vice President, Finance, IT, and Communications, Okmetic
Oyj, tel. +358 5028 0286, e-mail: juha.jaatinen@okmetic.com


Distribution:
NASDAQ OMX Helsinki Ltd
Principal media
www.okmetic.fi


OKMETIC IN BRIEF

Take it higher

Okmetic is a technology company which supplies tailor-made silicon wafers for
sensor and semiconductor industries and sells its technological expertise to the
solar cell industry. Okmetic provides its customers with solutions that boost
their competitiveness and profitability.

Okmetic's silicon wafers are part of a further processing chain that produces
end products that improve human interaction and quality of life. The company's
products are based on high-tech expertise that generates added value for
customers, innovative product development and an extremely efficient production
process.

Okmetic has a worldwide clientele and sales network, production plants in
Finland and in the United States as well as license-based production in Japan
and in China.

Ocmetic's shares are listed on the NASDAQ OMX Helsinki Ltd under the trading
symbol OKM1V. Additional information can be found on the company's website:
www.okmetic.com.

[HUG#1601832]

OKME1012.pdf